- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Myelofibroses in China
Total 33 results
-
The First Affiliated Hospital of Xiamen UniversityRecruitingPrimary MyelofibrosisChina
-
Qilu Hospital of Shandong UniversityRecruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingModerate and High Risk MyelofibrosisChina
-
First Affiliated Hospital of Zhejiang UniversityZhejiang Cancer Hospital; First People's Hospital of Hangzhou; Second Affiliated... and other collaboratorsRecruiting
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompleted
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompletedMyelofibrosisChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruiting
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompleted
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompleted
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Completed
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompletedPrimary Myelofibrosis (PMF) | Post-polycythemia Vera Myelofibrosis(Post-PV MF) | Post-essential Thrombocythemia Myelofibrosis(Post-ET MF)China
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruiting
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdTerminatedMyelodysplastic Syndromes | Myelofibrosis | Myeloproliferative NeoplasmsChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Karyopharm Therapeutics IncActive, not recruitingMyelofibrosisSpain, China, Poland, United States, France, Greece, Italy
-
Incyte CorporationNovartisCompletedMyelofibrosisFrance, United Kingdom, China, United States, Netherlands, Germany, Italy, Austria
-
AbbVieActive, not recruitingMyelofibrosis (MF)United States, Australia, Austria, Belgium, Bulgaria, Canada, Croatia, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Russian Federation, Serbia, South Africa, Spain, Sweden, Taiwan, Turkey and more
-
AbbVieActive, not recruitingMyelofibrosis (MF)United States, Australia, Austria, Belgium, Bulgaria, Canada, Croatia, Czechia, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, Puerto Rico, Russian Federation, Serbia, South... and more
-
CelgeneCompletedPrimary Myelofibrosis | MPN-associated MyelofibrosisUnited States, Netherlands, France, Australia, Italy, United Kingdom, Canada, Germany, China, Spain, Belgium, Austria, Poland, Sweden, Japan, Russian Federation
-
Chengdu Zenitar Biomedical Technology Co., LtdRecruitingMyeloproliferative Neoplasm (MPN) | Myelofibrosis,MFChina
-
Incyte CorporationRecruitingAnemia | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, France, Italy, Japan, United Kingdom, Canada
-
Sumitomo Pharma America, Inc.RecruitingMyelofibrosisUnited States, Belgium, France, Japan, Australia, Italy, United Kingdom
-
Incyte CorporationRecruitingMyelofibrosis | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome | Relapsed or Refractory Primary Myelofibrosis | Secondary Myelofibrosis (Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis) | ET...United States, Spain, Japan, Italy, Finland, United Kingdom, Canada
-
Incyte CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia Vera MyelofibrosisUnited States, Spain, United Kingdom, Korea, Republic of, China, Japan, France, Turkey, Germany, Israel, Poland, Belgium, Italy, Austria, Denmark, Finland, Norway
-
CelgeneRecruitingPrimary Myelofibrosis | Myeloproliferative Disorders | Anemia | Myelofibrosis | Post-Polycythemia Vera MyelofibrosisFrance, Belgium, Spain, Australia, Canada, United States, Korea, Republic of, Romania, Japan, Israel, Italy, Austria, China, Czechia, Germany, Greece, Ireland, Poland, United Kingdom, Hong Kong, Hungary, Lebanon, Argentina, Chile, Colombia and more
-
Incyte CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia Vera MyelofibrosisUnited States, Spain, United Kingdom, Korea, Republic of, Belgium, France, Israel, China, Japan, Italy, Germany, Taiwan, Poland, Austria, Finland, Hungary, Norway, Romania, Turkey
-
CelgeneRecruitingBeta-thalassemia | Myelodysplastic Syndromes (MDS) | Myeloproliferative Neoplasm(MPN)-Associated MyelofibrosisUnited States, Japan, United Kingdom, Turkey, Greece, France, Australia, Belgium, Bulgaria, Canada, Germany, Israel, Italy, Malaysia, Spain, Sweden, Taiwan, Thailand, Tunisia, Lebanon, China, Netherlands
-
Shandong UniversityWithdrawnMyeloproliferative Disorders | Polycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Chronic Myeloid LeukemiaChina
-
Novartis PharmaceuticalsCompletedAsian Phase II Study of INC424 in Patients With Primary Myelofibrosis (MF), Post-PV MF or Post-ET MFPrimary Myelofibrosis (MF) | Post-Polycythemia Vera (PV) MF | Post-Essential Thrombocythemia (ET) MFTaiwan, Japan, Korea, Republic of, China
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post-Polycythemia VeraAustralia, Austria, Belgium, China, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Ireland, United Kingdom
-
Hangzhou GluBio Pharmaceutical Co., Ltd.RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Polycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Myeloid MalignancyChina
-
Novartis PharmaceuticalsRecruitingAcute Myeloid Leukemia | Primary Myelofibrosis | Polycythemia Vera | Thalassemia | Graft Versus Host DiseaseKorea, Republic of, Italy, Belgium, Japan, Germany, Australia, Bulgaria, Chile, China, Denmark, Greece, Hungary, Israel, Lebanon, Poland, Portugal, Russian Federation, Slovakia, South Africa, Spain, Sweden, Thailand, India, Mexico, Turkey, Fran...